Statistics

Total Visits

Views
LONG-TERM (104-WEEK) EFFICACY AND SAFETY PROFILE OF APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A PHASE III, RANDOMIZED, CONTROLLED TRIAL AND OPEN-LABEL EXTENSION (PALACE 1)51

Select a period of time:

Number of views in the range

Views
LONG-TERM (104-WEEK) EFFICACY AND SAFETY PROFILE OF APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A PHASE III, RANDOMIZED, CONTROLLED TRIAL AND OPEN-LABEL EXTENSION (PALACE 1)36

Views

Views
March 202515
April 202512
May 20251
June 20250
July 20256
August 20251
September 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Hong Kong10
United States2
Turkey2
Argentina1
Brazil1
Colombia1
Ecuador1
Spain1
Kenya1
 

Top cities views

Views
Hong Kong10
Istanbul2
Council Bluffs1
Fayetteville1
Latacunga1
Nairobi1
Pretoria1
Sorocaba1
Viedma1
Yarumal1